**
The US Supreme Court convened on 27 April 2026, to deliberate on a landmark case that could redefine the legal landscape surrounding glyphosate, the controversial herbicide at the heart of numerous cancer-related lawsuits. As justices engaged with arguments concerning the balance of state versus federal regulatory power, demonstrators gathered outside the court, clamouring for accountability from agrochemical giants, particularly the former Monsanto Company, now under Bayer’s ownership.
Glyphosate Under Scrutiny
The case, known as Monsanto v. Durnell, revolves around the herbicide glyphosate, a key ingredient in Roundup, which has been linked to cancer in various studies. In 2015, the World Health Organization classified glyphosate as a probable human carcinogen, intensifying scrutiny over its use. Bayer has faced over 100,000 lawsuits from individuals claiming that their non-Hodgkin lymphoma was caused by exposure to glyphosate products. The company has been compelled to pay billions in settlements, yet it maintains that its products are safe.
During the Supreme Court proceedings, lawyers for Monsanto argued that under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the company should not be held liable for failing to issue cancer warnings if the Environmental Protection Agency (EPA) has not identified such risks. The EPA currently states that glyphosate is “unlikely” to cause cancer, a position that figures prominently in Monsanto’s defence.
The Legal Tug-of-War
Paul Clement, representing Monsanto, asserted that FIFRA is unequivocal in preventing pesticide manufacturers from altering safety warnings without express approval from the EPA. He cautioned against undermining this federal structure, arguing that it would expose companies to excessive liability, jeopardising the agricultural sector.
Conversely, opposing counsel Ashley Keller argued that FIFRA does not provide the sweeping immunity claimed by Monsanto. He highlighted flaws in the EPA’s registration process, stating that it had not adequately reviewed glyphosate as mandated by law. Keller noted that a previous ruling by the Ninth Circuit Court of Appeals had vacated the EPA’s findings on glyphosate’s safety due to procedural shortcomings.
The justices posed challenging questions, probing the implications of Monsanto’s arguments on public health and consumer rights. While the court’s liberal justices expressed scepticism towards Monsanto’s position, the inclinations of the remaining justices remained unclear.
Public Outcry and Protest
Outside the Supreme Court, activists rallied in support of those affected by glyphosate, chanting slogans such as “people over poison.” Organised by the Maha movement, the protests were bolstered by the presence of lawmakers, including Democratic Representative Chellie Pingree from Maine. Pingree emphasised the bipartisan nature of the rally, noting a shared commitment to safeguarding food and environmental safety.
Protesters voiced their concerns over the Trump administration’s endorsement of glyphosate production as a national security issue, alongside the solicitor general’s legal support for Monsanto. Zen Honeycutt, founder of Moms Across America, articulated the need for accountability, stating, “These companies must have accountability and it starts today.”
Implications of the Ruling
Bayer expressed optimism that a favourable ruling would bring an end to ongoing litigation, framing the case as a question of regulatory uniformity. The company contended that differing state laws regarding pesticide warnings could create chaos in agricultural practices, undermining the reliability of food supply chains.
With the Supreme Court expected to issue its ruling this summer, the outcome of this case will not only determine the future of glyphosate liability but also set a precedent for how pesticide manufacturers are regulated in the United States.
Why it Matters
The implications of this case extend far beyond the courtroom. A ruling in favour of Monsanto could significantly weaken consumer rights and diminish the ability of states to enforce their own safety standards. As the nation grapples with the intersection of agricultural practices and public health, the Supreme Court’s decision will resonate throughout the legal and environmental landscapes, shaping future regulatory frameworks and potentially impacting the health of countless individuals. The stakes are monumental, not just for Bayer and Monsanto, but for the broader societal commitment to protecting public health in the face of powerful corporate interests.
